OLR1 and COVID-19: In addition, COVID-19 patients in intensive care have been shown to have increased LOX-1 expression compared to those not in intensive care and has been suggested as a plausible characteristic to identify patients at greater risk of thrombosis, a severe and often fatal complication associated with COVID-19 [202].